Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | PKM | P14618 | 3/20 | 1.00 |
| ▸ | CA12 | O43570 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | CA3 | P07451 | 2/20 | 1.00 |
| ▸ | CA4 | P22748 | 2/20 | 1.00 |
| ▸ | CA6 | P23280 | 2/20 | 1.00 |
| ▸ | CA5A | P35218 | 2/20 | 1.00 |
| ▸ | SNCA | P37840 | 2/20 | 1.00 |
| ▸ | CA7 | P43166 | 2/20 | 1.00 |
| ▸ | CA9 | Q16790 | 2/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 1.00 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 1.00 |
| ▸ | CSNK2B | P67870 | 1/20 | 1.00 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 1.00 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ferulate SCHEMBL15673 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL1908219 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL30210805 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL1703377 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL15674 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL30760602 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL29362602 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL29481134 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL30880441 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL1908222 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119083240-A | Environment-friendly oil-proof waterproof packaging paper and preparation method thereof | 广州市宝绅科技应用有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118647726-A | Process for the production of 3-phenylpropionic acid analogues | 丸善制药株式会社 | 2024-09-13 | — | — | CN | claimed |
| CN-117304408-B | Preparation method of transparent modified polypropylene macromolecular nucleating agent similar to DBS | 杭州师范大学 | 2024-07-16 | — | — | CN | claimed |
| CN-117304408-A | Preparation method of transparent modified polypropylene macromolecular nucleating agent similar to DBS | 杭州师范大学 | 2023-12-29 | — | — | CN | claimed |
| CN-114853628-B | Docosahexaenoic acid acyl ester derivative and preparation method and application thereof | 自然资源部第三海洋研究所 | 2023-10-13 | — | — | CN | claimed |
| CN-116355139-A | Modified polypropylene with adjustable grafting, crosslinking and degradation, preparation method and application thereof | 杭州师范大学 | 2023-06-30 | — | — | CN | claimed |
| WO-2022172500-A1 | METHOD FOR MASS SPECTROMETRY OF ORGANIC SYNTHETIC COMPOUND | 株式会社 島津製作所 | 2022-08-18 | — | — | WO | claimed |
| CN-114853628-A | Docosahexaenoic acid ester derivative and preparation method and application thereof | 自然资源部第三海洋研究所 | 2022-08-05 | — | — | CN | claimed |
| CN-116687774-B | Water-soluble composition containing ferulic acid and whitening and soothing frozen film containing composition | 广州环亚化妆品科技股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4638788-A1 | ANALYSIS OF ANALYTES AND SPATIAL GENE EXPRESSION | 10X Genomics, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250304986-A1 | MODIFIED CEREAL GRAIN | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2025-10-02 | — | — | US | disclosed |
| US-20250228806-A1 | AMPK ACTIVATOR, MOTOR FUNCTION IMPROVING AGENT, MUSCULAR ENDURANCE IMPROVING AGENT, AND MUSCLE ATROPHY PREVENTING AGENT | MARUZEN PHARMACEUTICALS CO., LTD. (JP) | 2025-07-17 | — | — | US | disclosed |
| CN-120114340-A | Preparation method of composite powder, product and application | 上海上美化妆品股份有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20250171750-A1 | Modified Polyketide Synthase Enzymes and Uses Thereof | BGENE GENETICS (FR) | 2025-05-29 | — | — | US | disclosed |
| CN-114449906-A | Angiotensin converting enzyme inhibitor, antihypertensive agent, and food or drink | 丸善制药株式会社 | 2022-05-06 | — | — | CN | disclosed |
| CN-114349655-A | Ferulic acid derivatives, and preparation method and application thereof | 河北农业大学 | 2022-04-15 | — | — | CN | disclosed |
| WO-2022072060-A1 | SERUMS FOR REDUCING LIPID PEROXIDATION | L'OREAL (FR) | 2022-04-07 | — | — | WO | disclosed |
| WO-2022056220-A2 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | REFORM BIOLOGICS, INC. (US) | 2022-03-17 | — | — | WO | disclosed |
| CN-113667622-B | Burkholderia gladioli A1-07 and application thereof | 陕西海斯夫生物工程有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-109709249-B | Comprehensive quality evaluation method based on radix scrophulariae multi-active component detection | 湖南药圣堂中药科技有限公司 | 2022-01-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228806-A1 | AMPK ACTIVATOR, MOTOR FUNCTION IMPROVING AGENT, MUSCULAR ENDURANCE IMPROVING AGENT, AND MUSCLE ATROPHY PREVENTING AGENT | PRKAG1, PRKAB1, PRKAG2 | KDM4E 3400/4885PKM 195/4885CA12 4848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.